Literature DB >> 3886401

Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives.

R J Fruncillo, H H Rotmensch, P H Vlasses, J R Koplin, B N Swanson, R K Ferguson.   

Abstract

The effect on arterial pressure of incremental doses of norepinephrine (2 to 10 micrograms/min) and angiotensin II (50 to 800 ng/min) administered over 10 min periods was studied in sodium-replete hypertensive patients after crossover oral treatments with placebo, captopril 50 mg in a single dose, captopril 50 mg three times daily for one week and hydrochlorothiazide 50 mg daily for a week. Neither captopril nor hydrochlorothiazide affected the dose response to infusions of angiotensin II. In comparison to placebo responses, however, both single and multiple-dose captopril therapy, and hydrochlorothiazide attenuated the pressor responses to infusions of norepinephrine. Captopril significantly depressed angiotensin converting enzyme activity from pre-dose levels and angiotensin II infusions significantly elevated plasma aldosterone concentrations. These results confirm findings reported for single dose captopril in normotensive volunteers and indicate that attenuation of the vascular responsiveness to sympathetic stimulation may contribute to the antihypertensive effects of captopril and hydrochlorothiazide therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886401     DOI: 10.1007/bf00635700

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  27 in total

1.  Effect of chlorothiazide on vascular reactivity.

Authors:  W R BEAVERS; W P BLACKMORE
Journal:  Proc Soc Exp Biol Med       Date:  1958-05

2.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

3.  Pathogenic and therapeutic significance of cardiovascular pressor reactivity as related to plasma catecholamines in borderline and established essential hypertension.

Authors:  P Weidmann; M Grimm; A Meier; Z Glück; G Keusch; I Minder; C Beretta-Piccoli
Journal:  Clin Exp Hypertens       Date:  1980       Impact factor: 1.749

4.  Hydrochlorothiazide-induced sympathetic hyperactivity in hypertensive patients.

Authors:  C R Lake; M G Ziegler; M D Coleman; I J Kopin
Journal:  Clin Pharmacol Ther       Date:  1979-10       Impact factor: 6.875

5.  Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.

Authors:  R H Fagard; A K Amery; P J Lijnen; T M Reybrouck
Journal:  Kidney Int       Date:  1980-05       Impact factor: 10.612

6.  Angiotensin converting enzyme activity in human serum: relationship to enzyme inhibitor in vivo and in vitro.

Authors:  B N Swanson; M Hichens; P Mojaverian; R K Ferguson; P H Vlasses; M Dudash
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1981-09

7.  Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man.

Authors:  N K Hollenberg; W R Chenitz; D F Adams; G H Williams
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

8.  A specific orally active inhibitor of angiotensin-converting enzyme in man.

Authors:  R K Ferguson; G A Turini; H R Brunner; H Gavras; D N McKinstry
Journal:  Lancet       Date:  1977-04-09       Impact factor: 79.321

9.  Implication of endogenous prostaglandin system in the antihypertensive effect of captopril, SQ 14225, in low renin hypertension.

Authors:  K Abe; T Itoh; Y Imai; M Sato; T Haruyama; Y Sakurai; T Goto; Y Otsuka; K Yoshinaga
Journal:  Jpn Circ J       Date:  1980-05

10.  The opposing effects of chronic angiotensin-converting enzyme blockade by captopril on the responses to exogenous angiotensin II and vasopressin vs. norepinephrine in rats.

Authors:  F Spertini; H R Brunner; B Waeber; H Gavras
Journal:  Circ Res       Date:  1981-05       Impact factor: 17.367

View more
  4 in total

1.  A comparison of the haemodynamic and hormonal effects of low and conventional dose cyclopenthiazide in normal volunteers.

Authors:  G E McVeigh; M McMaster; T Linton; E Whitehead; G D Johnston
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 3.  Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.

Authors:  K L Duchin; D N McKinstry; A I Cohen; B H Migdalof
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

4.  The effect of acute and chronic captopril therapy on baroreflex function in man.

Authors:  G B Kondowe; A H Deering; J G Riddell; G D Johnston; D W Harron
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.